Oramed Pharmaceuticals Inc Financial Flexibility Index
Oramed Pharmaceuticals Inc financial flexibility index. Oramed Pharmaceuticals Inc (ORMP) has a Financial Flexibility Index of -0.10x as of March 2026. Free cash flow of $-2.91 Million (operating CF $-2.92 Million minus capex $5.00K) represents 0% of total liabilities ($30.57 Million). See ORMP FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Oramed Pharmaceuticals Inc (2003–2025)
Financial flexibility index of Oramed Pharmaceuticals Inc from 2003 to 2025. Historical Financial Flexibility Index trend for Oramed Pharmaceuticals Inc across 22 annual periods. Check Oramed Pharmaceuticals Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Oramed Pharmaceuticals Inc Financial Flexibility Index by Year (2003–2025)
Oramed Pharmaceuticals Inc financial flexibility index by year from 2003 to 2025. Year-by-year free cash flow to debt coverage for Oramed Pharmaceuticals Inc. For the full cash flow conversion analysis, see Oramed Pharmaceuticals Inc (ORMP) cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.23x | $-7.21 Million | $-9.14 Million | $31.12 Million | ▲ +72.6% |
| 2024 | -0.85x | $-8.39 Million | $-8.41 Million | $9.93 Million | ▼ -385.4% |
| 2023 | -0.17x | $-10.04 Million | $-10.29 Million | $57.66 Million | ▲ +93.5% |
| 2022 | -2.69x | $-28.21 Million | $-28.70 Million | $10.49 Million | ▼ -48.4% |
| 2021 | -1.81x | $-20.81 Million | $-21.18 Million | $11.48 Million | ▼ -72.3% |
| 2020 | -1.05x | $-12.36 Million | $-12.44 Million | $11.75 Million | ▼ -24.2% |
| 2019 | -0.85x | $-12.93 Million | $-12.94 Million | $15.27 Million | ▲ +5.9% |
| 2018 | -0.90x | $-14.65 Million | $-14.66 Million | $16.29 Million | ▼ -200.8% |
| 2017 | -0.30x | $-5.82 Million | $-5.83 Million | $19.47 Million | ▼ -206.7% |
| 2016 | 0.28x | $4.66 Million | $4.66 Million | $16.64 Million | ▲ +108.6% |
| 2015 | -3.24x | $-4.95 Million | $-4.95 Million | $1.53 Million | ▲ +19.3% |
| 2014 | -4.02x | $-4.05 Million | $-4.07 Million | $1.01 Million | ▲ +37.2% |
| 2013 | -6.40x | $-3.39 Million | $-3.40 Million | $529.41K | ▼ -322.3% |
| 2012 | -1.52x | $-2.30 Million | $-2.30 Million | $1.52 Million | ▲ +45.1% |
| 2011 | -2.76x | $-1.66 Million | $-1.67 Million | $602.02K | — |
| 2010 | 0.00x | $0.00 | $-1.42 Million | $620.62K | ▲ +100.0% |
| 2009 | -4.35x | $-2.25 Million | $-2.25 Million | $515.66K | ▼ -130.7% |
| 2008 | -1.89x | $-1.72 Million | $-1.84 Million | $913.95K | ▼ -341.3% |
| 2007 | -0.43x | $-609.00K | $-611.00K | $1.42 Million | ▲ +28.0% |
| 2006 | -0.59x | $-361.61K | $-361.61K | $608.91K | ▲ +32.3% |
| 2005 | -0.88x | $-40.43K | $-40.44K | $46.07K | ▲ +78.1% |
| 2003 | -4.00x | $-40.00K | $-40.00K | $10.00K | — |